Risk

GettyImages/Waldemarus

BIOPRODUCTION CONGRESS DUBLIN 2017

HPRA tells drug makers how to get ‘GMP inspection-ready’

By Flora Southey

Firms should identify risks prior to inspection, make staff available during regulator visits, and respond promptly post-inspection when undergoing GMP site checks, says Ireland’s Health Products Regulatory Authority (HPRA).

Pfizer offers update on risk-sharing deals with Icon, Parexel

Dispatches from DIA

Pfizer offers update on risk-sharing deals with Icon, Parexel

By Zachary Brennan

Three years after Pfizer began strategic partnerships with CROs Icon and Parexel, and the companies are still ironing out differences and tweaking their relationships, Mark Sanders, senior director of global sourcing, told attendees at DIA’s annual conference.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers